CTOs on the Move

Jelmar, LLC

www.clrbrands.com

 
Jelmar manufacturers CLR Brands and Tarn-X branded cleaning products. These products are available in food, drug and mass retailers. Jelmar has been a growing, evolving company since its inception in 1949. The company began when Manny Gutterman established a national sales representative organization, Manny Gutterman & Associates, Inc. This new company was dedicated to selling all types of proprietary products to chain drug, variety, hardware and department stores. Tarn-X® Tarnish Remover, during the late 1960s, became one of the first products that used the phrase "AS SEEN ON TV" in commercials and on packaging. Tarn-X has ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Almaden Press

Almaden Press is a Burtonsville, MD-based company in the Business Services sector.

Frans Maas / Furness Logistics

Frans Maas / Furness Logistics is a Minneapolis, MN-based company in the Business Services sector.

Hair Technology

Hair Technology is a Jacksonville, FL-based company in the Business Services sector.

Legacy Capital PA

With Legacy Capital, were investors ourselves and know what a hassle it can be to work with other hard money lenders in Pennsylvania. See our hard money programs...

Applied BioCode, Inc.

Applied BioCode focuses on research and development, manufacturing, and commercialization of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The HQ of the company is at Los Angles, California. The company develops, manufactures, and commercializes multiplex diagnostic testing products. Applied BioCode, Inc. has combined "digital barcodes" with immunochemistry and molecular probes to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The microscale BMB, with a diameter of human hair, is tagged with immunochemistry or molecular probes, allowing the digital barcode to be easily scanned and accurately identified for a very high number (4,096 barcodes) of biological targets with no ambiguity. Applied BioCode, Inc. products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. The company has currently received FDA Clearance for the BioCode® MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP). The Gastrointestinal Pathogen Panel (GPP) has also obtained the CE-Mark for use in European countries conforming to CE-Mark regulations. In the face of the COVID-19 pandemic, Applied BioCode, Inc. also manufactures a BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). Applied BioCode, Inc. also partners with a variety of diagnostic and pharmaceutical companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary diagnostics.